Biolife Solutions (BLFS) Income from Non-Controlling Interests (2014 - 2016)
Biolife Solutions (BLFS) reported Income from Non-Controlling Interests of -$241638.0 for Q4 2016, up 14.19% year-over-year from -$211602.9 in Q1 2016, and up 18.63% quarter-over-quarter from -$296974.0 in Q3 2016.
Biolife Solutions (BLFS) Income from Non-Controlling Interests (2014 - 2016) Analysis & Trends
Biolife Solutions (BLFS) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$241638.0 in Q4 2016.
- Income from Non-Controlling Interests for Q4 2016 came in at -$241638.0, up 14.19% year-over-year; the trailing twelve-month figure through Sep 2017 was -$241638.0 (up 79.96% YoY), and the FY2016 annual result was -$1.2 million, down 49.2% from the prior year.
- Income from Non-Controlling Interests grew to -$241638.0 in Q4 2016 per BLFS's latest filing, from -$296974.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$83045.0 in Q4 2014 and troughed at -$363629.0 in Q2 2016.
- A 3-year average of -$225601.2 and a median of -$241638.0 in 2016 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2015 and 2016: Income from Non-Controlling Interests tumbled 239.11% in 2015, then gained 14.19% in 2016.
- A 3-year view of Income from Non-Controlling Interests shows it stood at -$83045.0 in 2014, then plunged by 239.11% to -$281610.0 in 2015, then advanced by 14.19% to -$241638.0 in 2016.
- Business Quant data shows BLFS's Income from Non-Controlling Interests at -$241638.0 in Q4 2016, -$296974.0 in Q3 2016, and -$363629.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -241,638.00 |
| Sep 30, 2016 | -296,974.00 |
| Jun 30, 2016 | -363,629.00 |
| Mar 31, 2016 | -263,685.00 |
| Dec 31, 2015 | -281,610.00 |
| Sep 30, 2015 | -223,031.00 |
| Jun 30, 2015 | -156,016.00 |
| Mar 31, 2015 | -120,783.00 |
| Dec 31, 2014 | -83,045.00 |